2Seventy Bio Inc (TSVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||
| Net Income | -320,594 | N/A | N/A |
| Depreciation Amortization | 12,587 | N/A | N/A |
| Accounts payable and accrued liabilities | 14,611 | N/A | N/A |
| Other Working Capital | 35,144 | N/A | N/A |
| Other Operating Activity | 50,295 | 0 | 0 |
| Operating Cash Flow | $-207,957 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| PPE Investments | -59,765 | N/A | N/A |
| Investing Cash Flow | $-59,765 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 267,722 | 0 | 0 |
| Financing Cash Flow | $267,722 | $N/A | $N/A |
| Net Cash Flow | $N/A | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -207,957 | N/A | N/A |
| Capital Expenditure | -59,765 | N/A | N/A |
| Free Cash Flow | -267,722 | 0 | 0 |